{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:17:06Z","timestamp":1782908226317,"version":"3.54.5"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Health and Medical Research Council of Australia"},{"name":"Medical Research Future Fund of Australia"},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lions Cord Blood Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Neonatal cell therapy applications are increasing; however, data on allogeneic cell therapy are limited.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To summarize evidence on allogeneic cell therapy in term and preterm neonates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Cochrane Central Register of Controlled Trials, Embase, Ovid Medline, and various registries were searched for studies investigating the safety, feasibility, and efficacy of allogeneic cell therapy in neonates. Two authors independently selected the articles, extracted data, and assessed the risk of bias.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Twelve published (153 infants) and 21 ongoing studies were included. These studies predominantly sourced allogeneic cells from umbilical cord blood (UCB). Mesenchymal stromal cells (MSCs) were the main cell type used (134 of 153 infants); others included UCB-derived total nucleated cells (TNCs) and human amnion epithelial cells (hAECs). Applications included bronchopulmonary dysplasia (BPD; 113 infants), Krabbe disease (13 infants), intraventricular haemorrhage (10 infants), perinatal arterial ischemic stroke (10 infants), hypoxic-ischaemic encephalopathy (6 infants), and necrotizing enterocolitis (1 infant). Nine out of 12 studies did not report any serious adverse events (SAEs) related to cell administration. Three studies reported SAEs, such as graft versus host disease (GVHD) in 5 infants (UCB-derived TNCs for Krabbe disease); and transient cardiorespiratory compromise in 1 infant (hAECs for BPD). Data on efficacy outcomes were limited.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The safety and feasibility of allogeneic cell therapy applications in neonates are available, mainly from the use of MSCs. Further safety data for other cell types are required, and the risk of GVHD in different settings needs to be determined. Efficacy studies are largely lacking for all cell types.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Protocol Registration<\/jats:title>\n                  <jats:p>The protocol was registered with PROSPERO (registration number CRD42023397876), the international prospective register for systematic reviews (https:\/\/www.crd.york.ac.uk\/PROSPERO).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/stcltm\/szad048","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T20:28:09Z","timestamp":1692649689000},"page":"651-664","source":"Crossref","is-referenced-by-count":18,"title":["Allogeneic Cell Therapy Applications in Neonates: A Systematic Review"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6185-3694","authenticated-orcid":false,"given":"Abdul","family":"Razak","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Monash University , Melbourne, VIC , Australia"},{"name":"Monash Newborn, Monash Children\u2019s Hospital , Melbourne, VIC , Australia"},{"name":"The Ritchie Centre, Hudson Institute of Medical Research , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Monash University , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney A","family":"McDonald","sequence":"additional","affiliation":[{"name":"The Ritchie Centre, Hudson Institute of Medical Research , Melbourne, VIC , Australia"},{"name":"Department of Obstetrics and Gynaecology, Monash University , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod W","family":"Hunt","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Monash University , Melbourne, VIC , Australia"},{"name":"Monash Newborn, Monash Children\u2019s Hospital , Melbourne, VIC , Australia"},{"name":"The Ritchie Centre, Hudson Institute of Medical Research , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne L","family":"Miller","sequence":"additional","affiliation":[{"name":"The Ritchie Centre, Hudson Institute of Medical Research , Melbourne, VIC , Australia"},{"name":"Department of Obstetrics and Gynaecology, Monash University , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9664-4182","authenticated-orcid":false,"given":"Atul","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Monash University , Melbourne, VIC , Australia"},{"name":"Monash Newborn, Monash Children\u2019s Hospital , Melbourne, VIC , Australia"},{"name":"The Ritchie Centre, Hudson Institute of Medical Research , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"2023100516271021400_CIT0001","first-page":"138","article-title":"Stem cell-based therapies for the newborn lung and brain: possibilities and challenges","volume-title":"Semin Perinatol","author":"Mitsialis","year":"2016"},{"key":"2023100516271021400_CIT0002","first-page":"968","article-title":"Benefits and obstacles to cell therapy in neonates: the INCuBAToR (Innovative Neonatal Cellular Therapy for Bronchopulmonary Dysplasia: Accelerating Translation of Research)","volume-title":"Stem Cells Transl Med","author":"Thebaud","year":"2021"},{"key":"2023100516271021400_CIT0003","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-1-78548-254-0.50003-3","article-title":"Stem cells at the core of cell therapy","volume-title":"Stem Cells","author":"Arrighi","year":"2018"},{"key":"2023100516271021400_CIT0004","first-page":"333","article-title":"Umbilical cord blood cells for treatment of cerebral palsy; timing and treatment options","volume-title":"Pediatr Res","author":"McDonald","year":"2018"},{"key":"2023100516271021400_CIT0005","first-page":"200","article-title":"Could cord blood cell therapy reduce preterm brain injury","volume-title":"Front Neurol","author":"Li","year":"2014"},{"key":"2023100516271021400_CIT0006","first-page":"2","article-title":"Stem cell-based therapy for neonatal lung disease: it is in the juice","volume-title":"Pediatr Res","author":"Fung","year":"2014"},{"key":"2023100516271021400_CIT0007","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3389\/fphys.2019.00540","article-title":"The potential of stem cell therapy to repair white matter injury in preterm infants: lessons learned from experimental models","volume":"10","author":"Vaes","year":"2019","journal-title":"Front Physiol"},{"key":"2023100516271021400_CIT0008","first-page":"578984","article-title":"Stem cells as therapy for necrotizing enterocolitis: a systematic review and meta-analysis of preclinical studies","volume-title":"Front Pediatr","author":"Villamor-Martinez","year":"2020"},{"key":"2023100516271021400_CIT0009","first-page":"3142","article-title":"Stem cell therapy for neonatal hypoxic-ischemic encephalopathy: a systematic review of preclinical studies","volume-title":"Int J Mol Sci","author":"Serrenho","year":"2021"},{"key":"2023100516271021400_CIT0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41390-022-02208-3","article-title":"Mesenchymal stem cell therapy in perinatal arterial ischemic stroke: systematic review of preclinical studies","author":"Lehnerer","year":"2022","journal-title":"Pediatr Res"},{"key":"2023100516271021400_CIT0011","first-page":"2373","article-title":"Stem cell therapy for congenital heart disease: a systematic review","volume-title":"Circulation","author":"Tsilimigras","year":"2017"},{"key":"2023100516271021400_CIT0012","first-page":"17","article-title":"Transplantation of human adipose tissue-derived mesenchymal stem cells restores the neurobehavioral disorders of rats with neonatal hypoxic-ischemic encephalopathy","volume-title":"Cell Med","author":"Park","year":"2013"},{"issue":"2","key":"2023100516271021400_CIT0013","first-page":"342","article-title":"Human mesenchymal stem cells attenuate experimental bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia","volume":"8","author":"Chou","year":"2016","journal-title":"Am J Transl Res"},{"key":"2023100516271021400_CIT0014","first-page":"693","article-title":"Transplantation of placenta-derived mesenchymal stem cells reduces hypoxic-ischemic brain damage in rats by ameliorating the inflammatory response","volume-title":"Cell Mol Immunol","author":"Ding","year":"2017"},{"key":"2023100516271021400_CIT0015","first-page":"65","article-title":"Mesenchymal stem cells suppress neuronal apoptosis and decrease IL-10 release via the TLR2\/NFkappaB pathway in rats with hypoxic-ischemic brain damage","volume-title":"Mol Brain","author":"Gu","year":"2015"},{"key":"2023100516271021400_CIT0016","first-page":"475","article-title":"Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia","volume-title":"Thorax","author":"Pierro","year":"2013"},{"key":"2023100516271021400_CIT0017","first-page":"228","article-title":"Angiogenic and anti-inflammatory properties of mesenchymal stem cells from cord blood: soluble factors and extracellular vesicles for cell regeneration","volume-title":"Eur J Cell Biol","author":"Montemurro","year":"2016"},{"key":"2023100516271021400_CIT0018","first-page":"1621","article-title":"Neural stem cell treatment for perinatal brain injury: a systematic review and meta-analysis of preclinical studies","volume-title":"Stem Cells Transl Med","author":"Smith","year":"2021"},{"key":"2023100516271021400_CIT0019","first-page":"101844","article-title":"Prevention for moderate or severe BPD with intravenous infusion of autologous cord blood mononuclear cells in very preterm infants-a prospective non-randomized placebo-controlled trial and two-year follow up outcomes","volume-title":"EClinicalMedicine","author":"Zhuxiao","year":"2023"},{"key":"2023100516271021400_CIT0020","first-page":"1129","article-title":"Stem cells for bronchopulmonary dysplasia in preterm infants: a randomized controlled phase II trial","volume-title":"Stem Cells Transl Med","author":"Ahn","year":"2021"},{"key":"2023100516271021400_CIT0021","first-page":"135","article-title":"Umbilical cord blood and cord tissue-derived cell therapies for neonatal morbidities: current status and future challenges","volume-title":"Stem Cells Transl Med","author":"Zhou","year":"2022"},{"key":"2023100516271021400_CIT0022","first-page":"591693","article-title":"The potential of mesenchymal stromal cell as therapy in neonatal diseases","volume-title":"Front Pediatr","author":"Liau","year":"2020"},{"key":"2023100516271021400_CIT0023","first-page":"726","article-title":"Stem-cell therapy in neonates - an option","volume-title":"J Perinat Med","author":"Wellmann","year":"2022"},{"key":"2023100516271021400_CIT0024","first-page":"458","article-title":"Feasibility of cord blood collection for autologous cell therapy applications in extremely preterm infants","volume-title":"Cytotherapy","author":"Zhou","year":"2023"},{"key":"2023100516271021400_CIT0025","first-page":"260","article-title":"Using risk of Bias 2 to assess results from randomised controlled trials: guidance from cochrane","volume-title":"BMJ Evid Based Med","author":"Flemyng","year":"2023"},{"key":"2023100516271021400_CIT0026","author":"Wells"},{"key":"2023100516271021400_CIT0027","first-page":"60","article-title":"Methodological quality and synthesis of case series and case reports","volume-title":"BMJ Evid Based Med","author":"Murad","year":"2018"},{"key":"2023100516271021400_CIT0028","first-page":"49","article-title":"Two-year follow-up outcomes of premature infants enrolled in the phase i trial of mesenchymal stem cells transplantation for bronchopulmonary dysplasia","volume-title":"J Pediatr","author":"Ahn","year":"2017"},{"key":"2023100516271021400_CIT0029","first-page":"847","article-title":"Mesenchymal stem cells for severe intraventricular hemorrhage in preterm infants: phase i dose-escalation clinical trial","volume-title":"Stem Cells Transl Med","author":"Ahn","year":"2018"},{"key":"2023100516271021400_CIT0030","first-page":"250","article-title":"Successful mesenchymal stem cell application in supraventricular tachycardia-related necrotizing enterocolitis: a case report","volume-title":"Fetal Pediatr Pathol","author":"Akduman","year":"2021"},{"key":"2023100516271021400_CIT0031","first-page":"2233","article-title":"Long-term functional outcomes after hematopoietic stem cell transplant for early infantile Krabbe disease","volume-title":"Biol Blood Marrow Transplant","author":"Allewelt","year":"2018"},{"key":"2023100516271021400_CIT0032","first-page":"1337","article-title":"Off-label mesenchymal stromal cell treatment in two infants with severe bronchopulmonary dysplasia: clinical course and biomarkers profile","volume-title":"Cytotherapy","author":"Alvarez-Fuente","year":"2018"},{"key":"2023100516271021400_CIT0033","first-page":"528","article-title":"Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study","volume-title":"Lancet Neurol","author":"Baak","year":"2022"},{"key":"2023100516271021400_CIT0034","first-page":"344","article-title":"A new hope in the treatment of intraventricular haemorrhage in preterm infants: mesenchymal stem cells","volume-title":"Turk Neurosurg","author":"Bozkaya","year":"2022"},{"key":"2023100516271021400_CIT0035","first-page":"966","article-title":"Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial","volume-title":"J Pediatr","author":"Chang","year":"2014"},{"key":"2023100516271021400_CIT0036","first-page":"S192","article-title":"Phase I trial of allogeneic umbilical cord tissue-derived mesenchymal stromal cells in neonates with hypoxic-ischemic encephalopathy","volume-title":"Cytotherapy","author":"Cotten","year":"2020"},{"key":"2023100516271021400_CIT0037","first-page":"2069","article-title":"Transplantation of umbilical-cord blood in babies with infantile Krabbe\u2019s disease","volume-title":"N Engl J Med","author":"Escolar","year":"2005"},{"key":"2023100516271021400_CIT0038","first-page":"1105","article-title":"Steroid-induced hypertrophic cardiomyopathy following stem cell transplantation in a neonate: a case report","volume-title":"Bone Marrow Transplant","author":"Lesnik","year":"2001"},{"key":"2023100516271021400_CIT0039","first-page":"628","article-title":"First-in-human administration of allogeneic amnion cells in premature infants with bronchopulmonary dysplasia: a safety study","volume-title":"Stem Cells Transl Med","author":"Lim","year":"2018"},{"key":"2023100516271021400_CIT0040","first-page":"209","article-title":"Safety of intratracheal administration of human umbilical cord blood derived mesenchymal stromal cells in extremely low birth weight preterm infants","volume-title":"J Pediatr","author":"Powell","year":"2019"},{"key":"2023100516271021400_CIT0041"},{"key":"2023100516271021400_CIT0042"},{"key":"2023100516271021400_CIT0043"},{"key":"2023100516271021400_CIT0044"},{"key":"2023100516271021400_CIT0045"},{"key":"2023100516271021400_CIT0046"},{"key":"2023100516271021400_CIT0047"},{"key":"2023100516271021400_CIT0048"},{"key":"2023100516271021400_CIT0049"},{"key":"2023100516271021400_CIT0050"},{"key":"2023100516271021400_CIT0051"},{"key":"2023100516271021400_CIT0052"},{"key":"2023100516271021400_CIT0053"},{"key":"2023100516271021400_CIT0054"},{"key":"2023100516271021400_CIT0055"},{"key":"2023100516271021400_CIT0056"},{"key":"2023100516271021400_CIT0057"},{"key":"2023100516271021400_CIT0058"},{"key":"2023100516271021400_CIT0059"},{"key":"2023100516271021400_CIT0060","first-page":"e026265","article-title":"Human amnion cells for the prevention of bronchopulmonary dysplasia: a protocol for a phase I dose escalation study","volume-title":"BMJ Open","author":"Baker","year":"2019"},{"key":"2023100516271021400_CIT0061","doi-asserted-by":"crossref","volume-title":"Safety of Allogenic Human Cord Blood-Derived Mononuclear Cells for Extreme Preterms Infants at High Risk of Death: A Descriptive Study","author":"Chen","DOI":"10.21203\/rs.3.rs-72840\/v1"},{"key":"2023100516271021400_CIT0062","author":"Register"},{"key":"2023100516271021400_CIT0063","volume-title":"Prevention and treatment of Bronchopulmonary Dysplasia with Allogeneic Cord blood mononuclear cells (Identifier ChiCTR2000035227)","author":"Registry"},{"key":"2023100516271021400_CIT0064","first-page":"2","article-title":"Safety of allogeneic umbilical cord blood infusions for the treatment of neurological conditions: a systematic review of clinical studies","volume-title":"Cytotherapy","author":"Paton","year":"2022"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/12\/10\/651\/51888323\/szad048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/12\/10\/651\/51888323\/szad048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T16:28:05Z","timestamp":1696523285000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/12\/10\/651\/7246860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":64,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,8,21]]},"published-print":{"date-parts":[[2023,10,5]]}},"URL":"https:\/\/doi.org\/10.1093\/stcltm\/szad048","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10,1]]},"published":{"date-parts":[[2023,8,21]]}}}